Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.32830
Abstract: Current ovarian cancer maintenance therapy is limited by toxicity and no proven impact on overall survival. To study a maintenance strategy targeted at missense mutant p53, we hypothesized that the release of mutant p53 from… read more here.
Keywords: mutant p53; ovarian cancer; cancer; p53 ... See more keywords